3 results match your criteria: "3-279 Edmonton Clinic Health Academy[Affiliation]"

Background: Meaningful performance measurement requires indicators to be scientifically robust and strategically focused. For many circumpolar states, indicators aligned with national strategies may ignore the priorities of northern, remote, or Indigenous populations. The aim of this project was to identify contextually appropriate performance indicators for maternity care in circumpolar regions.

View Article and Find Full Text PDF

Bringing regenerative medicines to the clinic: the future for regulation and reimbursement.

Regen Med

September 2016

Philip S Orsino Cell Therapy Facility, Princess Margaret Cancer Centre, 610 University Avenue, Suite 5-303, Toronto, ON, M5G 2M9, Canada.

Significant investments in regenerative medicine necessitate discussion to align evidentiary requirements and decision-making considerations from regulatory, health system payer and developer perspectives. Only with coordinated efforts will the potential of regenerative medicine be realized. We report on discussions from two workshops sponsored by NICE, University of Alberta, Cell Therapy Catapult and Centre for Commercialization of Regenerative Medicine.

View Article and Find Full Text PDF

The global landscape of stem cell clinical trials.

Regen Med

January 2014

School of Public Health, 3-279 Edmonton Clinic Health Academy, 11405-87 Ave, University of Alberta, Edmonton, AB, T6G 1C9, Canada.

Aim: To provide a comprehensive analysis of clinical trials (CTs) listed in worldwide registries involving new applications for stem cell-based treatments and account for the role of industry.

Materials & Methods: We developed a data set of 4749 stem cell CTs up to 2013 in worldwide registries. We defined 1058 novel CTs (i.

View Article and Find Full Text PDF